Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04899089
Other study ID # 2053302
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 28, 2021
Est. completion date June 1, 2023

Study information

Verified date October 2023
Source University of Missouri-Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Older adults (60+ years of age) who meet criteria for mild cognitive impairment and insomnia will be randomly assigned to cognitive training or trivia training and will complete measures of anxiety, sleep, cognition (objective, self-efficacy), and arousal at baseline, and post-intervention. For cognitive training, participants will be provided with login information to access the computerized training, and will complete 8 weeks (45 mins 3x/week) of cognitive training. For trivia training, participants will receive weekly emails that contain trivia assignments that they will complete for 8 weeks (45 mins 3x/week). We will evaluate short-term (i.e., post-training) effects of the two training conditions on subjective anxiety, sleep, arousal, and subjective and objective cognition.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date June 1, 2023
Est. primary completion date June 1, 2023
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: 1. 60+ yrs of age 2. meet criteria for mild cognitive impairment 3. no neurological or psychiatric illness or dementia 4. non-gamers (<2 hour of video/brain training games/week over last 2 yrs) 5. proficient in English (reading and writing) 6. meet clinical dx criteria for Insomnia (e.g., insomnia complaints for 6+ months, complaints occur despite adequate opportunity and circumstances for sleep, consist of one of the following: difficulty falling asleep, staying asleep, or waking up too early, and daytime dysfunction due to insomnia) Exclusion Criteria: 1. unable to provide informed consent 2. unable to undergo randomization 3. other sleep disorder (e.g., sleep apnea, restless legs syndrome) 4. severe untreated psychiatric comorbidity 5. psychotropic or other medications that alter sleep (unless stabilized for 6 months) 6. uncorrected visual/auditory impairments 7. participation in nonpharmacological tx for sleep/fatigue/mood/cognition outside the current study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Training
The computerized training exercises and brain games help stimulate cognitive functions while providing real-time monitoring on the evolution of participants' skills.
Trivia Training
The computerized trivia training asks participants to answer general questions related to pop culture, science, geography, etc. Participants can use online sources to search for answers and will be provided feedback on their accuracy.

Locations

Country Name City State
United States University of Missouri Columbia Missouri

Sponsors (1)

Lead Sponsor Collaborator
University of Missouri-Columbia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Objective Cognition - Computerized Cognitive Tasks Complete computerized tasks. These tasks will measure cognitive functions (e.g., processing speed, attention, memory). Up to 10 weeks
Primary Subjective Cognitive Self-Efficacy. - Cognitive Failures Questionnaire A 25 item questionnaire. Participants rate from 0 (never) to 4 (very often) frequency of cognitive errors. Higher scores indicate lower cognitive self-efficacy. Up to 10 weeks
Primary Subjective Behavioral Sleep- Electronic Daily Sleep Diaries Electronic Daily Sleep Diaries. Online diaries completed each morning (~5 mins) during the study. Diaries measure sleep onset latency, wake time after sleep onset, total sleep time, and sleep quality. Up to 10 days
Primary Subjective Behavioral Sleep- Insomnia Severity Index Brief self-report measure of current perception of insomnia symptom severity, distress and daytime impairment. Commonly used in insomnia treatment outcome research. Up to 10 weeks
Primary Objective Sleep-Watchpat Single night objective sleep recording via a wrist worn device. Up to 10 weeks
Secondary Physiological Arousal- Heart Rate Variability CorSense monitor assessed 5 min heart rate recordings both at rest. Time index variables: SDNN (standard deviation of normal to normal heartbeat intervals) Impact of game related experience will be measured at baseline
Secondary Anxiety - State-Trait Anxiety Inventory Inventory that asks respondents to rate how true 20 self-descriptive statements (e.g., I feel calm) are on a 4-point scale (1 = not at all, 4 = very much so). Typically, respondents are asked to rate statements according to how they generally feel (trait-anxiety scale) and how they feel in the current moment (state-anxiety scale). Total scores range from 20 to 80, with higher scores indicating greater maladjustment. Up to 10 weeks
Secondary Game-related experience- Sessions and duration played During the intervention phase the cognitive training group will play games and will need to log the days and duration played. Up to 10 weeks
Secondary Circadian Rhythm- Morningness-Eveningness Questionnaire 19-item questionnaire that assesses preference for morning, afternoon, and evening activities. Total score reflects degree of "morningness" or "eveningness" type. Up to 10 weeks
Secondary Perceived Stress- Perceived Stress Scale Subjective Arousal- Perceived Stress Scale Perceived Stress Scale is a self-report measure of how life situations are perceived as stressful. The scale consists of 15 items corresponding to everyday situation and participants are asked to rate on a scale from 0 (never) to 4 (very often) how often they felt or thought a specific way. Higher scores correspond to higher perceived stress. Up to 10 weeks
Secondary Subjective Arousal- Arousal Predisposition Scale Arousal Predisposition Scale is a 12-item inventory that has been designed to measure the degree to which an individual experiences arousal. Higher scores indicate greater predisposition to arousal. Up to 10 weeks
Secondary Game Engagement Questionnaire Questionnaire assessing the experience of the game. Up to 10 weeks
Secondary Mood-Depression-Beck Depression Inventory-II 21-item inventory that asks respondents to rate on a scale of 0 (no depressive feelings) to 3 (most depressive feelings) their feelings towards various aspects of daily living/situations. Higher total scores indicate worse depressive symptoms. Up to 10 weeks
Secondary Alcohol Use - Alcohol Use Disorder Test 10-item questionnaire that assess the frequency of alcohol use and problems associated with alcohol use over the past year. Baseline
Secondary Physical Activity - International Physical Activity Questionnaire 7- item questionnaire assessing the different kinds of physical activities that the participant does as pat of their everyday life. Up to 10 weeks
Secondary Personality - Big Five Inventory 10 question assessment measuring personality Baseline
Secondary Computer Proficiency- Computer Proficiency Questionnaire This questionnaire asks about participants' ability to perform a number of tasks with a computer. Will be examined as a covariate. Baseline
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A